Metabolomics‐driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease-Reference-Cited by-同舟云学术

Metabolomics‐driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease

Published:2019-06-25 Issue:3 Volume:150 Page:282-295
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Huang Wanqiu¹²,Xu Yazhou²,Zhang Yuxin³,Zhang Pei¹⁴⁵^ORCID,Zhang Qianqian¹²,Zhang Zunjian¹²,Xu Fengguo¹²^ORCID

Affiliation:

1. Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education) State Key Laboratory of Natural Medicine China Pharmaceutical University Nanjing P. R. China

2. Jiangsu Key Laboratory of Drug Screening China Pharmaceutical University Nanjing P. R. China

3. Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School Nanjing P. R.China

4. Gunma University Initiative for Advanced Research (GIAR), Gunma University Gunma Japan

5. Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics Karolinska Institutet Stockholm Sweden

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.14774

Reference65 articles.

1. Purinergic signalling in the nervous system: an overview

2. Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

3. Modeling neuroinflammatory pathogenesis of Parkinson’s disease

4. Metabolomic profiling to develop blood biomarkers for Parkinson's disease

5. Modulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease;Neural Regeneration Research;2024-07-10

2. Metabolic Disturbances in the Gut-brain Axis of a Mouse Model of MPTP-induced Parkinsonism Evaluated by Nuclear Magnetic Resonance;Neuroscience;2023-08

3. Adenosinergic Pathway in Parkinson’s Disease: Recent Advances and Therapeutic Perspective;Molecular Neurobiology;2023-02-14

4. Rhynchophylline-encapsulating core-shell nanoparticles to overcome blood-brain-barrier and inhibit drug efflux for efficient anti-Parkinson therapy;Applied Materials Today;2023-02

5. Integrated transcriptomics and metabolomics analysis reveals that C3 and C5 are vital targets of DuZhi Wan in protecting against cerebral ischemic injury;Biomedicine & Pharmacotherapy;2022-11